Search research articles
Contact Us
Filters
Showing results (121-130 of 197) with videos related to
Page
of 20
Sort By:
Frontiers in Psychiatry
|
January 13, 2018
A Biomarker to Differentiate between Primary and Cocaine-Induced Major Depression in Cocaine Use Disorder: The Role of Platelet IRAS/Nischarin (I<sub>1</sub>-Imidazoline Receptor)
Benjamin Keller, Joan-Ignasi Mestre-Pinto, María Álvaro-Bartolomé, et al.
Journal of Attention Disorders
|
August 24, 2012
Criteria and Concurrent Validity of Adult ADHD Section of the Psychiatry Research Interview for Substance and Mental Disorders
Josep Antoni Ramos-Quiroga, Laura Díaz-Digon, Marina Comín, et al.
Spanish Journal of Psychiatry and Mental Health
|
October 2, 2025
PRISM-5 update: Adaptation and validation of the Spanish version interview for dual diagnosis assessment based on DSM-5 criteria
Claudio Tamarit, Maria Pellicer-Roca, María Alias-Ferrí, et al.
Biology
|
August 27, 2021
A Comparison of Acute Pharmacological Effects of Methylone and MDMA Administration in Humans and Oral Fluid Concentrations as Biomarkers of Exposure
Lourdes Poyatos, Esther Papaseit, Eulalia Olesti, et al.
Journal of Clinical Medicine
|
February 25, 2022
Abuse Potential of Cathinones in Humans: A Systematic Review
Lourdes Poyatos, Adrián Torres, Esther Papaseit, et al.
Actas Espanolas De Psiquiatria
|
June 25, 2019
Relationship between craving and impulsivity in patients with alcohol dependence with or without dual disorders in an outpatient treatment center: a descriptive study
María Robles-Martínez, Miguel Ángel García-Carretero, Juan Gibert Rahola, et al.
Psychological Medicine
|
May 10, 2023
A systematic review of digital interventions for smoking cessation in patients with serious mental illness
Luis Martinez Agulleiro, Bhagyashree Patil, Joseph Firth, et al.
Clinical Pharmacology and Therapeutics
|
March 1, 2019
Dose-Response Pharmacological Study of Mephedrone and Its Metabolites: Pharmacokinetics, Serotoninergic Effects, and Impact of CYP2D6 Genetic Variation
Eulàlia Olesti, Magí Farré, Marcel Lí Carbó, et al.
Journal of Clinical Psychopharmacology
|
September 17, 2008
The consequences of 3,4-methylenedioxymethamphetamine induced CYP2D6 inhibition in humans
Brian O'Mathúna, Magi Farré, Amin Rostami-Hodjegan, et al.
Drug Metabolism and Pharmacokinetics
|
June 8, 2012
Changes in CYP1A2 activity in humans after 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) administration using caffeine as a probe drug
Samanta Yubero-Lahoz, Ricardo Pardo, Magí Farre, et al.
Page
of 20
Search research articles
Search
Showing results (121-130 of 197) with videos related to
Sort By:
Page
of 20
Frontiers in Psychiatry
|
January 13, 2018
A Biomarker to Differentiate between Primary and Cocaine-Induced Major Depression in Cocaine Use Disorder: The Role of Platelet IRAS/Nischarin (I<sub>1</sub>-Imidazoline Receptor)
Benjamin Keller, Joan-Ignasi Mestre-Pinto, María Álvaro-Bartolomé, et al.
Journal of Attention Disorders
|
August 24, 2012
Criteria and Concurrent Validity of Adult ADHD Section of the Psychiatry Research Interview for Substance and Mental Disorders
Josep Antoni Ramos-Quiroga, Laura Díaz-Digon, Marina Comín, et al.
Spanish Journal of Psychiatry and Mental Health
|
October 2, 2025
PRISM-5 update: Adaptation and validation of the Spanish version interview for dual diagnosis assessment based on DSM-5 criteria
Claudio Tamarit, Maria Pellicer-Roca, María Alias-Ferrí, et al.
Biology
|
August 27, 2021
A Comparison of Acute Pharmacological Effects of Methylone and MDMA Administration in Humans and Oral Fluid Concentrations as Biomarkers of Exposure
Lourdes Poyatos, Esther Papaseit, Eulalia Olesti, et al.
Journal of Clinical Medicine
|
February 25, 2022
Abuse Potential of Cathinones in Humans: A Systematic Review
Lourdes Poyatos, Adrián Torres, Esther Papaseit, et al.
Actas Espanolas De Psiquiatria
|
June 25, 2019
Relationship between craving and impulsivity in patients with alcohol dependence with or without dual disorders in an outpatient treatment center: a descriptive study
María Robles-Martínez, Miguel Ángel García-Carretero, Juan Gibert Rahola, et al.
Psychological Medicine
|
May 10, 2023
A systematic review of digital interventions for smoking cessation in patients with serious mental illness
Luis Martinez Agulleiro, Bhagyashree Patil, Joseph Firth, et al.
Clinical Pharmacology and Therapeutics
|
March 1, 2019
Dose-Response Pharmacological Study of Mephedrone and Its Metabolites: Pharmacokinetics, Serotoninergic Effects, and Impact of CYP2D6 Genetic Variation
Eulàlia Olesti, Magí Farré, Marcel Lí Carbó, et al.
Journal of Clinical Psychopharmacology
|
September 17, 2008
The consequences of 3,4-methylenedioxymethamphetamine induced CYP2D6 inhibition in humans
Brian O'Mathúna, Magi Farré, Amin Rostami-Hodjegan, et al.
Drug Metabolism and Pharmacokinetics
|
June 8, 2012
Changes in CYP1A2 activity in humans after 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) administration using caffeine as a probe drug
Samanta Yubero-Lahoz, Ricardo Pardo, Magí Farre, et al.
Page
of 20